Zichuan Liu

机构：China Pharmaceutical University, Tianjin University, Tianjin Synthetic Material Research Institute (China), Guangdong Polytechnic Normal University, State Key Laboratory of Synthetic Chemistry, Tianjin Hospital, Nanjing University · ORCID：0000-0002-5709-8497

发表论文 106 篇 · 总被引 2081 次 · h-index 25

代表论文

• Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T strategies in solid tumor immunotherapy (2025 · Frontiers in Immunology · 被引 34)
• LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice (2024 · Journal of Controlled Release · 被引 27)
• Breaking barriers: advancing cellular therapies in autoimmune disease management (2024 · Frontiers in Immunology · 被引 16)
• De novo assembly and delivery of synthetic megabase-scale human DNA into mouse early embryos (2025 · Nature Methods · 被引 14)
• Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma (2025 · Scientific Reports · 被引 4)
• Iron, copper and disulfide dysregulation: molecular crossroads of metabolic cell death in melanoma progression (2025 · Frontiers in Pharmacology · 被引 3)